Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-12-19
1977-04-26
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
106137, 106193J, 106209, 106299, 106308C, 106308P, 424360, 424361, 424362, 424363, A61K 2902
Patent
active
040201520
ABSTRACT:
A radiological contrast product comprising a non-toxic radiopaque salt selected from the group consisting of barium titanate and barium zirconate and a method for conducting radiological examinations of the gastro-intestinal tract of a mammal with said product is disclosed herein.
REFERENCES:
patent: 1216980 (1917-02-01), Gardner
patent: 1396924 (1921-11-01), Buckman
patent: 1411839 (1922-04-01), Buckman
patent: 1429841 (1922-09-01), Buckman
patent: 2260826 (1941-10-01), Booge
patent: 2841503 (1958-07-01), Graham et al.
patent: 3592185 (1971-07-01), Frei et al.
patent: 3705140 (1972-12-01), Bernardi et al.
Clarke Vera C.
Meyers Albert T.
Thann & Mulhouse
LandOfFree
Barium titanate and barium zirconate in radiological contrast pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Barium titanate and barium zirconate in radiological contrast pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Barium titanate and barium zirconate in radiological contrast pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2087574